Literature DB >> 15650640

Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer.

Christopher G Willett1, Carlos Fernandez Del Castillo, Helen A Shih, Saveli Goldberg, Peter Biggs, Jeffrey W Clark, Gregory Lauwers, David P Ryan, Andrew X Zhu, Andrew L Warshaw.   

Abstract

SUMMARY BACKGROUND DATA: To analyze the effects of a treatment program of intraoperative electron beam radiation therapy (IOERT) and external beam radiation therapy and chemotherapy on the outcome of patients with unresectable or locally advanced pancreatic cancer.
METHODS: From 1978 to 2001, 150 patients with unresectable and nonmetastatic pancreatic cancer received IOERT combined with external beam radiation therapy and 5-fluorouracil-based chemotherapy for definitive treatment.
RESULTS: The 1-, 2-, and 3-year actuarial survival rates of all 150 patients were 54%, 15%, and 7%, respectively. Median and mean survival rates were 13 and 17 months, respectively. Long-term survival has been observed in 8 patients. Five patients have survived beyond 5 years and 3 more between 3 and 4 years. There was a statistically significant correlation of survival to the diameter of treatment applicator (a surrogate for tumor size) used during IOERT. For 26 patients treated with a small-diameter applicator (5 cm or 6 cm), the 2- and 3-year actuarial survival rates were 27% and 17%, respectively. In contrast, none of the 11 patients treated with a 9-cm-diameter applicator survived beyond 18 months. Intermediate survival rates were seen for patients treated with a 7- or 8-cm-diameter applicator. Operative mortality was 0.6%, and postoperative and late complications were 20% and 15%, respectively.
CONCLUSIONS: A treatment strategy employing IOERT has resulted in long-term survival in 8 of 150 patients with unresectable pancreatic cancer. Survival benefit was limited to patients with small tumors. Enrollment of selected patients with small tumors into innovative protocols employing this treatment approach is appropriate.

Entities:  

Mesh:

Year:  2005        PMID: 15650640      PMCID: PMC1356915          DOI: 10.1097/01.sla.0000152016.40331.bb

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  14 in total

Review 1.  Intraoperative radiation therapy for carcinoma of the stomach and pancreas.

Authors:  M Abe; Y Shibamoto; K Ono; M Takahashi
Journal:  Front Radiat Ther Oncol       Date:  1991

2.  Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?

Authors:  K D Lillemoe; J L Cameron; C J Yeo; T A Sohn; A Nakeeb; P K Sauter; R H Hruban; R A Abrams; H A Pitt
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

Review 3.  Intraoperatic electron beam irradiation in pancreatic cancer.

Authors:  C G Willett; A L Warshaw
Journal:  Front Biosci       Date:  1998-11-15

4.  Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

Authors:  J H Klinkenbijl; J Jeekel; T Sahmoud; R van Pel; M L Couvreur; C H Veenhof; J P Arnaud; D G Gonzalez; L T de Wit; A Hennipman; J Wils
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

5.  External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer.

Authors:  G E Roldan; L L Gunderson; D M Nagorney; J K Martin; D M Ilstrup; M A Holbrook; L K Kvols; D C McIlrath
Journal:  Cancer       Date:  1988-03-15       Impact factor: 6.860

6.  Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma.

Authors:  W U Shipley; W C Wood; J E Tepper; A L Warshaw; E L Orlow; S D Kaufman; G E Battit; G L Nardi
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

7.  Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer.

Authors:  L L Gunderson; J K Martin; L K Kvols; D M Nagorney; J M Fieck; H S Wieand; A Martinez; M J O'Connell; J D Earle; D C McIlrath
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-03       Impact factor: 7.038

8.  The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma.

Authors:  J E Tepper; W U Shipley; A L Warshaw; G L Nardi; W C Wood; E L Orlow
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

9.  Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Radiation Therapy Oncology Group.

Authors:  J E Tepper; D Noyes; J M Krall; W T Sause; H B Wolkov; R R Dobelbower; J Thomson; J Owens; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-10       Impact factor: 7.038

10.  High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer.

Authors:  G R Garton; L L Gunderson; D M Nagorney; J H Donohue; J K Martin; D C McIlrath; S S Cha
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-12-01       Impact factor: 7.038

View more
  26 in total

Review 1.  The role of radiotherapy in locally advanced pancreatic carcinoma.

Authors:  Ruchika Gutt; Stanley L Liauw; Ralph R Weichselbaum
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-13       Impact factor: 46.802

Review 2.  Rationale and appropriate use of chemotherapy and radiotherapy for pancreatic ductal adenocarcinoma.

Authors:  Robert de W Marsh; Thomas George
Journal:  Curr Gastroenterol Rep       Date:  2006-04

3.  Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer.

Authors:  Jonathan B Ashman; Adyr A Moss; William G Rule; Matthew G Callister; K Sudhakar Reddy; David C Mulligan; Joseph M Collins; Giovanni De Petris; Leonard L Gunderson; Mitesh Borad
Journal:  J Gastrointest Oncol       Date:  2013-12

4.  FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience.

Authors:  Jason E Faris; Lawrence S Blaszkowsky; Shaunagh McDermott; Alexander R Guimaraes; Jackie Szymonifka; Mai Anh Huynh; Cristina R Ferrone; Jennifer A Wargo; Jill N Allen; Lauren E Dias; Eunice L Kwak; Keith D Lillemoe; Sarah P Thayer; Janet E Murphy; Andrew X Zhu; Dushyant V Sahani; Jennifer Y Wo; Jeffrey W Clark; Carlos Fernandez-del Castillo; David P Ryan; Theodore S Hong
Journal:  Oncologist       Date:  2013-05-08

5.  The role of radiotherapy in management of pancreatic cancer.

Authors:  Fen Wang; Parvesh Kumar
Journal:  J Gastrointest Oncol       Date:  2011-09

6.  Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.

Authors:  Sophie Cai; Theodore S Hong; Saveli I Goldberg; Carlos Fernandez-del Castillo; Sarah P Thayer; Cristina R Ferrone; David P Ryan; Lawrence S Blaszkowsky; Eunice L Kwak; Christopher G Willett; Keith D Lillemoe; Andrew L Warshaw; Jennifer Y Wo
Journal:  Cancer       Date:  2013-09-04       Impact factor: 6.860

7.  Multicriteria optimization in intensity-modulated radiation therapy treatment planning for locally advanced cancer of the pancreatic head.

Authors:  Theodore S Hong; David L Craft; Fredrik Carlsson; Thomas R Bortfeld
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-15       Impact factor: 7.038

8.  Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.

Authors:  Sonali Rudra; Amol K Narang; Timothy M Pawlik; Hao Wang; Elizabeth M Jaffee; Lei Zheng; Dung T Le; David Cosgrove; Ralph H Hruban; Elliot K Fishman; Richard Tuli; Daniel A Laheru; Christopher L Wolfgang; Luis A Diaz; Joseph M Herman
Journal:  Pract Radiat Oncol       Date:  2012

9.  Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.

Authors:  Sunil Krishnan; Awalpreet S Chadha; Yelin Suh; Hsiang-Chun Chen; Arvind Rao; Prajnan Das; Bruce D Minsky; Usama Mahmood; Marc E Delclos; Gabriel O Sawakuchi; Sam Beddar; Matthew H Katz; Jason B Fleming; Milind M Javle; Gauri R Varadhachary; Robert A Wolff; Christopher H Crane
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-11       Impact factor: 7.038

10.  Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarker-directed therapy here?

Authors:  E V Tsvetkova; T R Asmis
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.